Cynthia Seidel Dugan Werewolf Therapeutics, Inc. (HOWL) insider trading activity
Cynthia Seidel Dugan is Chief Scientific Officer of Werewolf Therapeutics, Inc.. Currently has a direct ownership of 164,888 shares of HOWL, which is worth approximately $258,874. The most recent transaction as insider was on Jan 12, 2022, when has been sold 39,731 shares (Common Stock) at a price of $3.17 per share, resulting in proceeds of $125,947. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
165K
0%
3M change
0%
12M change
Total Value Held
$258,874
CS
Cynthia Seidel Dugan
Chief Scientific Officer
Cambridge, MA